ABSTRACT
BACKGROUND: Timely administration of post-exposure prophylaxis (PEP) can prevent rabies. For non-vaccinated persons, PEP consists of multiple vaccinations and rabies immunoglobulin (RIG) on indication. Since RIG is scarce, the need for PEP could be restricted through preventing animal contact and pre-exposure vaccination. We aimed to identify determinants for possible rabies exposure among travellers to provide more targeted pre-travel advice. METHOD: A case-control study was performed. Cases were defined as persons with a possible rabies exposure (category II or III injury according to WHO classification guidelines) in a rabies endemic country. Controls did not report exposure during travel. Multivariable logistic regression was performed. RESULTS: 229 cases and 1427 controls were included. Predictors (p < 0.05) of possible rabies exposure were young age, male sex, travelling to Western or Southeastern Asia, visiting a monkey park, pet ownership, previously visited the same country and considering oneself an experienced traveller. Negative predictors were travelling for business, visiting friends and relatives, and fear of animals. CONCLUSIONS: Pre-travel advice should take the identified predictors into account to provide better targeted information and pre-exposure prophylaxis.
Subject(s)
Rabies Vaccines , Rabies virus , Rabies , Animals , Case-Control Studies , Humans , Immunoglobulins , Male , Phobic Disorders , Post-Exposure Prophylaxis , Rabies/epidemiology , Rabies/prevention & control , TravelABSTRACT
INTRODUCTION: Despite sustained high vaccination coverage and a national guideline by the Health Council (HC-guideline) on tetanus postexposure prophylaxis (T-PEP), tetanus sporadically occurs in the Netherlands. This study aims to assess the added value of a bedside test for tetanus immunity (Tetanos Quick Stick (TQS); Ingen BioSciences Group, France), in the context of routine T-PEP in two adult cohorts: those born before introduction of tetanus toxoid vaccination in the National Immunization Programme (NIP) in 1957 (pre-NIP-cohort; n=196) and those born after (NIP-cohort; n=405). METHODS: Adults included at the time of visiting one of three participating EDs received T-PEP as per routine recommendations. Subsequently, a nurse performed the TQS and filled in a questionnaire. We compared the indication for T-PEP based on TQS results with those based on the HC-guideline and with actually administration of T-PEP, stratified by cohort. RESULTS: Among the pre-NIP and NIP-cohort, 16% and 9%, respectively, received T-PEP, while this was not indicated based on the HC-guideline. Furthermore, 8% and 7%, respectively, did not get T-PEP, although it was indicated by the guideline. Comparing the indication derived from the HC-guideline with TQS result found that 22% (pre-NIP-cohort) and 8% (NIP-cohort) were not eligible for T-PEP according to the HC-guideline but had a negative TQS. Conversely, 36% (pre-NIP-cohort) and 73% (NIP-cohort) were eligible for T-PEP according to the HC-guideline but had positive TQS, indicating sufficient tetanus protection. CONCLUSION: Use of the TQS would allow better targeting of T-PEP. Furthermore, stricter adherence to the HC-guideline can prevent overimmunisation and decrease the risk of tetanus.
Subject(s)
Point-of-Care Testing , Tetanus/diagnosis , Tetanus/immunology , Adult , Aged , Aged, 80 and over , Cohort Studies , Cross-Sectional Studies , Emergency Service, Hospital/organization & administration , Female , Humans , Immunization Programs/standards , Immunization Programs/statistics & numerical data , Male , Middle Aged , Netherlands , Surveys and QuestionnairesABSTRACT
BACKGROUND: Air travel has opened up opportunities for world transportation, but has also increased infectious disease transmission and public health risks. To control disease spread, airlines and governments are able to implement control measures in air travel. This study inventories experiences and applicability of infectious disease control measures. METHODS: A literature search was performed in PubMed, including studies between 1990 and 2013. Search terms included air travel terms and intervention terms. Interventions were scored according outcome, required resources, preparation, passenger inconvenience and passenger compliance. RESULTS: Provision of information to travelers, isolation, health monitoring, hygiene measures and vector control reportedly prevent disease spread and are well applicable. Contact tracing can be supportive in controlling disease spread but depend on disease characteristics. Exit and entry screening, quarantine and travel restrictions are unlikely to be very effective in preventing disease spread, while implementation requires extensive resources or travel implications. CONCLUSIONS: Control measures should focus on providing information towards travelers, isolation, health monitoring and hygiene measures. Appropriateness of measures depends on disease characteristics, and the required resources. As most studies analyze one type of measure in a particular situation, further research comparing the effectiveness of measures is recommended.
Subject(s)
Air Travel , Communicable Disease Control , Disease Outbreaks/prevention & control , Animals , Communicable Disease Control/standards , Contact Tracing , Disease Vectors , Humans , Hygiene , Patient Isolation , Public Health , Quarantine , TransportationABSTRACT
Rapid and wide dispersal of passengers after flights makes investigation of flight-related outbreaks challenging. An outbreak of Salmonella Heidelberg was identified in a group of Irish travellers returning from Tanzania. Additional international cases sharing the same flight were identified. Our aim was to determine the source and potential vehicles of infection. Case-finding utilized information exchange using experts' communication networks and national surveillance systems. Demographic, clinical and food history information was collected. Twenty-five additional cases were identified from Ireland, The Netherlands, Norway, USA and Canada. We conducted a case-control study which indicated a significant association between illness and consumption of milk tart (OR 10.2) and an egg dish (OR 6) served on-board the flight. No food consumed before the flight was associated with illness. Cases from countries other than Ireland provided supplementary information that facilitated the identification of likely vehicles of infection. Timely, committed international collaboration is vital in such investigations.
Subject(s)
Air Travel , Disease Outbreaks , Salmonella Food Poisoning/epidemiology , Adolescent , Adult , Aged , Analysis of Variance , Cohort Studies , Food Handling , Food Microbiology , Humans , Internationality , Ireland , Middle Aged , Salmonella Food Poisoning/microbiology , Tanzania , Young AdultABSTRACT
Two Dutch travellers were infected with oseltamivir-resistant influenza A(H1N1)pdm09 viruses with an H275Y neuraminidase substitution in early August 2012. Both cases were probably infected during separate holidays at the Catalonian coast (Spain). No epidemiological connection between the two cases was found, and neither of them was treated with oseltamivir before specimen collection. Genetic analysis of the neuraminidase gene revealed the presence of previously described permissive mutations that may increase the likelihood of such strains emerging and spreading widely.
Subject(s)
Antiviral Agents/pharmacology , Influenza A Virus, H1N1 Subtype/drug effects , Influenza, Human/virology , Oseltamivir/pharmacology , Travel , Adolescent , Drug Resistance, Viral/genetics , Humans , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/diagnosis , Influenza, Human/drug therapy , Molecular Sequence Data , Mutation , Netherlands , Neuraminidase/genetics , Sentinel Surveillance , Spain , Treatment Outcome , Young AdultABSTRACT
In February 2012 a rabid puppy dog was imported into Amsterdam, the Netherlands from Morocco via Spain. In a joint action between the Netherlands' Food and Consumer Product Safety Authority, the Public Health Service of Amsterdam and the Centre for Infectious Disease Control all exposed human and animal contacts were traced and, when necessary, provided with post-exposure prophylaxis. During the importation, the international legislations with respect to vaccination requirements were not fully obeyed by veterinarians and custom services.
Subject(s)
Contact Tracing , Dog Diseases/diagnosis , Post-Exposure Prophylaxis , Rabies virus/isolation & purification , Rabies/diagnosis , Rabies/veterinary , Animals , Commerce , Communicable Disease Control , Dog Diseases/transmission , Dog Diseases/virology , Dogs , Euthanasia, Animal , Humans , Morocco , Netherlands , Rabies/prevention & control , Rabies/transmission , Rabies/virology , Rabies Vaccines/administration & dosage , Spain , TravelABSTRACT
The 25 European overseas countries and territories (OCTs) are closely associated with the European Union (EU) through the four related UE Member States: Denmark, France, the Netherlands and the United Kingdom. In 2008 and 2009, these four EU Member States, in association with the European Centre for Disease Prevention and Control (ECDC), reviewed the OCTs' needs, with the objectives of documenting their capacity to prevent and respond to infectious diseases outbreaks, and identifying deficiencies. This Euroroundup is based on the review's main findings, and presents an overview of the OCTs' geography and epidemiology, briefly introduces the legal basis on which they are linked to the EU and describes the surveillance and infectious disease response systems. As a result of their diversity the OCTs have heterogeneous epidemiological profiles. A common factor, however, is that the main burden of disease is non-communicable. Nevertheless, OCTs remain vulnerable to infectious diseases outbreaks. Their capacity for surveillance, early detection and response to such outbreaks is generally limited, with laboratory capacity issues and lack of human resources. Avenues for capacity strengthening should be explored by the OCTs and the related EU Member States, in collaboration with ECDC and regional public health networks where these exist.
Subject(s)
Communicable Disease Control/methods , Communicable Diseases/epidemiology , Disease Outbreaks/prevention & control , Population Surveillance/methods , Europe/epidemiology , European Union , Humans , International Cooperation , Public HealthABSTRACT
In June 2008, three Dutch tourists participating in a mini-cruise in Turkey needed urgent repatriation for antitoxin treatment because of symptoms of botulism. Because there was a shortage of antitoxin in the Netherlands, an emergency delivery was requested from the manufacturer in Germany. An outbreak investigation was initiated into all nine cruise members, eight of whom developed symptoms. C. botulinum type B was isolated in stool culture from four of them. No other patients were notified locally. Food histories revealed locally purchased unprocessed black olives, consumed on board of the ship, as most likely source, but no left-overs were available for investigation. C. botulinum type D was detected in locally purchased canned peas, and whilst type D is not known to be a cause of human intoxication, its presence in a canned food product indicates an inadequate preserving process. With increasing tourism to areas where food-borne botulism is reported regularly special requests for botulism antitoxin may become necessary. Preparing an inventory of available reserve stock in Europe would appear to be a necessary and valuable undertaking.
Subject(s)
Botulinum Toxins , Botulism/epidemiology , Foodborne Diseases/epidemiology , Travel , Botulinum Antitoxin/therapeutic use , Botulinum Toxins/isolation & purification , Botulinum Toxins, Type A , Botulism/diagnosis , Botulism/drug therapy , Cluster Analysis , Food, Preserved/poisoning , Foodborne Diseases/diagnosis , Foodborne Diseases/drug therapy , Humans , Netherlands , TurkeyABSTRACT
BACKGROUND: Public health measures at sea ports have posed a challenge for public health competent authorities, especially in the context of the influenza pandemic of 2009. This paper discusses the response of authorities to notifications of infectious diseases on passenger ships and the importance of assessing the risks related to cases of influenza. It further provides options for health measures and considerations for decision making during a pandemic such as the influenza pandemic of 2009. DISCUSSION: Prevention and control of influenza have included action taken by both competent port authorities and ships' crews. Assessing the public health risk of each event reported from ships to competent authorities at ports is important before advice is given on implementation of control measures. Public health risk assessment involves appraisal of threats to passengers and crew on board the ship as well as to the population in the community. SUMMARY: Any public health measures taken should be necessary and proportional to the threat. Measures at ports cannot alone be effective in the prevention of the spread of a disease to the community since other means of transport play a major role. Measures taken on board ships can be effective in containing the disease. Consistent policy based on common protocols and carried out by competent authorities at local, national, European, or international levels are essential.
Subject(s)
Communicable Disease Control/methods , Decision Making , Influenza A Virus, H1N1 Subtype , Influenza, Human/prevention & control , Influenza, Human/transmission , Pandemics , Ships , Global Health , Health Policy , Humans , Influenza, Human/epidemiology , Risk Assessment , TravelABSTRACT
BACKGROUND: Nursing home influenza outbreaks occur in spite of established vaccination programs, and require rapid and sensitive laboratory confirmation for timely intervention. OBJECTIVES: To evaluate diagnostic approaches for rapid confirmation of nursing home influenza outbreaks. STUDY DESIGN: Influenza virus real-time PCR and Directigen Flu A+B enzyme immunoassay were performed on nasopharyngeal swabs, nasopharyngeal washes and throat swabs collected from residents with clinical suspicion of influenza during seven probable nursing home outbreaks in 2004-2005 and 2005-2006. The efficacy of specimen sampling and transport management by Public Health Service outbreak team was evaluated. RESULTS: PCR detected influenza RNA in 80% (68/85) of specimens from 81% (38/47) residents, confirming six suspected outbreaks. Immunoassay sensitivity was highest on nasopharyngeal swabs (38%; 11/29) with a positive predictive value of 100% compared to PCR. Nasopharyngeal swabs were equally sensitive to nasopharyngeal washes by PCR. Nasopharyngeal wash sampling appeared unpractical due to common underlying disability of residents. Outbreak team support was associated with a shorter time to PCR diagnosis compared to outbreaks with no logistical support (mean, 28.2h vs. 84h; P=0.05). CONCLUSIONS: Influenza real-time PCR on nasopharyngeal swabs, obtained by Public Health Service outbreak teams, enabled rapid and sensitive confirmation of nursing home influenza outbreaks.
Subject(s)
Disease Outbreaks , Influenza, Human/diagnosis , Influenza, Human/epidemiology , Orthomyxoviridae/isolation & purification , Aged , Aged, 80 and over , Antigens, Viral/analysis , Cross Infection/diagnosis , Cross Infection/epidemiology , Female , Humans , Immunoenzyme Techniques/methods , Male , Middle Aged , Netherlands , Nursing Homes , Orthomyxoviridae/chemistry , Orthomyxoviridae/genetics , Pharynx/virology , Predictive Value of Tests , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and SpecificitySubject(s)
Chlamydophila psittaci/isolation & purification , Ducks , Influenza A Virus, H5N1 Subtype/isolation & purification , Influenza in Birds/diagnosis , Pneumonia, Mycoplasma/diagnosis , Psittacosis/diagnosis , Animals , Ducks/virology , Germany/epidemiology , Humans , Influenza in Birds/epidemiology , Influenza in Birds/prevention & control , Male , Netherlands/epidemiology , Pneumonia, Mycoplasma/epidemiology , Pneumonia, Mycoplasma/prevention & control , Poultry Diseases/diagnosis , Poultry Diseases/epidemiology , Poultry Diseases/prevention & control , Psittacosis/epidemiology , Psittacosis/prevention & controlABSTRACT
The influenza vaccine is considered safe, but information on vaccine-related adverse events is limited and a nationwide overview of adverse events is lacking. In 2006, after deaths occurred in Israel and the Netherlands following influenza vaccination, the Dutch Ministry of Health, Welfare and Sport (VWS) asked the National Institute for Public Health and the Environment (RIVM) twice for a recommendation regarding the continuation of the national vaccination campaign. After 4 deaths were reported in Israel in October 2006 following administration of Vaxigrip, the Dutch vaccination campaign was suspended for one week. One month later, 4 additional deaths were reported after influenza vaccination in the Netherlands. The newly appointed outbreak management team concluded that a causal relationship between vaccination and the deaths was highly unlikely, based on data regarding the individual cases, background mortality rates and prior reports of adverse events. Further suspension of the vaccination campaign was deemed unnecessary this time. A centralised nationwide registry of adverse events has since been established to provide further insight into the incidence of adverse events following influenza vaccination. Physicians are advised to report potential adverse events following influenza vaccination to the Netherlands Pharmacovigilance Centre Lareb (www.lareb.nl).
Subject(s)
Adverse Drug Reaction Reporting Systems , Influenza Vaccines/adverse effects , Databases, Factual , Humans , Israel , NetherlandsABSTRACT
A 58-year-old woman was admitted due to a pseudomembranous pharyngitis. The patient had not been vaccinated against diphtheria. Corynebacterium ulcerans was cultured from a throat swab. The production of diphtheria toxin by these bacteria was demonstrated with PCR and an immunoprecipitation test. The patient was cared for in respiratory isolation and was treated with benzylpenicillin. She quickly recovered and was discharged four days after admission. A contact investigation did not reveal any dissemination of the toxin-producing C. ulcerans and a source was not found. In spite of the large-scale vaccination against diphtheria which has taken place in the Netherlands since 1953, a physician has to consider diphtheria in the differential diagnosis of patients who present with a clinical syndrome compatible with this disease. Either Corynebacterium diphtheriae or C. ulcerans could be the pathogen responsible.
Subject(s)
Corynebacterium/isolation & purification , Diphtheria/diagnosis , Penicillin G/therapeutic use , Penicillins/therapeutic use , Pharyngitis/microbiology , Corynebacterium/pathogenicity , Diagnosis, Differential , Diphtheria/drug therapy , Diphtheria/microbiology , Diphtheria Toxin/biosynthesis , Female , Humans , Middle Aged , Netherlands , Pharyngitis/diagnosis , Pharyngitis/drug therapyABSTRACT
Lassa, Ebola, Marburg and Crimean-Congo haemorrhagic fever viruses are the most important causes of viral haemorrhagic fever which is transmitted from person to person through contact with blood or excreta. A non-specific fever may be the initial symptom of viral haemorrhagic fever. By means of carefully noting where the patient has travelled, possible exposure to ill persons, vectors or an animal reservoir, and the incubation period (< or = 21 days versus longer), it is possible to estimate the risk of infection with one of these viruses. Using this approach it is possible to diagnose high-risk patients in good time and to take appropriate measures.
Subject(s)
Hemorrhagic Fevers, Viral/diagnosis , Hemorrhagic Fevers, Viral/therapy , Adult , Antiviral Agents/therapeutic use , Female , Fever/etiology , Hemorrhagic Fever, Crimean/diagnosis , Hemorrhagic Fever, Crimean/therapy , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/therapy , Humans , Lassa Fever/diagnosis , Lassa Fever/therapy , Marburg Virus Disease/diagnosis , Marburg Virus Disease/therapy , TravelABSTRACT
Two cases of Lassa fever have been reported in the Netherlands since viral haemorrhagic fevers became notifiable diseases in 1978. In 1980, an expatriate from Burkina Faso who was not seriously ill was confirmed by laboratory tests after his discharge from hospital. The second case occurred in 2000: the patient died on the 11th day of admission to hospital. The problems we faced in the management of this case and the contact investigation--more than one hundred contacts - highlighted the need for national recommendations in the Netherlands.